Document is current

Article History

Received: 29 January 2024

Accepted: 25 July 2024

First Online: 31 August 2024

Declarations

:

: A. Sajiki, None; K. Kataoka, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Otsuka, Bayer, Canon, Senju, Chugai, Beringer Ingelheim, Novartis), Support for attending meetings and/or travel (Bayer); J. Takeuchi, Grants or contracts (AMO), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Novartis, Santen, Bayer, Senju, Chugai); H. Ota, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Chugai, Novartis, Santen, Bayer); Y. Nakano, None; E. Horiguchi, None; H. Kaneko, None; H. Terasaki, Grants or contracts (ZEISS), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Novartis, Sanofi, Chugai, Senju, Alcon), Support for attending meetings and/or travel (Bayer); Y. Ito, Grants or contracts (HOYA, Senju, Santen, Alcon), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Topcon, Santen, Senju, Canon, Kowa, Chugai, Novartis, Bayer, Otsuka); K. Nishiguchi, Grants or contracts (Takara bio, Takeda, JCR Pharma, Alcon, Bayer, Novartis, Santen), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Alcon, Bayer, Novartis, Santen, Chugai, Kowa, Senju, Otsuka, Wakamoto), Patents planned, issued or pending (A gene therapy using genome editing with a single AAV vector).